Neuro-Oncology Reviews
Volume
26 Number 3
15 February 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 3, 15 February
Tiefenbach
J, Lu VM, Metzler AR, Palejwala A, Haider S, Ivan ME, Komotar RJ,
Shah
AH.
The
use of advanced neuroimaging modalities in the evaluation of
low-grade glioma in adults: a literature review.
Neurosurg
Focus.
2024 Feb;56(2):E3. doi:
10.3171/2023.11.FOCUS23649. PMID:
38301240. Review. ˍ
Ajithkumar
T, Avanzo M, Yorke E, Tsang DS, Milano MT, Olch AJ, Merchant TE,
Dieckmann K, Mahajan A, Fuji H, Paulino AC, Timmermann B, Marks
LB, Bentzen SM, Jackson A, Constine LS.
PENTEC
Organ-Specific Report: Brain and Brain Stem Necrosis After
Reirradiation for Recurrent Childhood Primary Central Nervous
System Tumors: A PENTEC Comprehensive Review.
Int
J Radiat Oncol Biol Phys.
2024 Feb 1:S0360-3016(24)00001-4. doi:
10.1016/j.ijrobp.2023.12.043. PMID:
38300187. Review˰ ˍ
Cuschieri
A, Pisani R, Agius S.
From
Trauma to Tumour: exploring post-TBI
glioblastoma
patient characteristics.
World
Neurosurg.
2024 Feb 1:S1878-8750(24)00144-X.
doi:
10.1016/j.wneu.2024.01.122. PMID:
38307194. Review˰ ˍ
Ebrahimnia M, Alavi S, Vaezi H, Karamat Iradmousa M, Haeri
A.
Exploring the vast potentials and
probable limitations of novel and nanostructured implantable drug
delivery systems for cancer treatment.
EXCLI
J. 2024 Feb 1;23:143-179. doi:
10.17179/excli2023-6747. PMID:
38487087. Review.
ˍ
McFaline-Figueroa JR.
Spinal Cord
Neoplasms.
Continuum
(Minneap Minn). 2024 Feb 1;30(1):99-118. doi:
10.1212/CON.0000000000001375. PMID:
38330474. Review˰
ˍ
Lee SG.
Editorial: 15 Years of
Frontiers in Cellular Neuroscience: astrocytes in brain
disease.
Front
Cell Neurosci. 2024 Feb 2;18:1374172. doi:
10.3389/fncel.2024.1374172. PMID:
38370033. Editorial. ˍ
*Doniselli
FM, Pascuzzo R, Mazzi F, Padelli F, Moscatelli M, Akinci
D'Antonoli T, Cuocolo R, Aquino D, Cuccarini V, Sconfienza
LM.
Quality
assessment of the MRI-radiomics studies for MGMT promoter
methylation prediction in glioma: a systematic review and
meta-analysis.
Eur
Radiol.
2024 Feb 3. doi:
10.1007/s00330-024-10594-x. PMID:
38308012. Review, Meta-analysis. ˍ
Sferruzza
G, Consoli S, Dono F, Evangelista G, Giugno A, Pronello E, Rollo
E, Romozzi
M, Rossi L, Pensato U.
A
systematic review of immunotherapy in high-grade glioma: learning
from the past to shape future perspectives.
Neurol
Sci.
2024
Feb 3. doi:
10.1007/s10072-024-07350-w. PMID:
38308708.
Review˰
ˍ
Huang
M, Li S, Li P, Kang Z, Zhang B, Li W.
Drug
clinical trials on high-grade gliomas: challenges and
hopes.
Cancer
Biol Med.
2024 Feb 5;20(12):j.issn.2095-3941.2023.0364. doi:
10.20892/j.issn.2095-3941.2023.0364. PMID:
38318805. Editorial. ˍ
Lucas D, Carvalho B, Tuna R, Linhares P.
Metabolic
Syndrome and Survival in Glioblastoma Patients: Retrospective
Cohort Study and Review of the Literature.
Cureus.
2024 Feb 5;16(2):e53641. doi:
10.7759/cureus.53641. PMID:
38449965. Observational study; Review. ˍ
Aebisher D, Przygórzewska A, Myśliwiec A, Dynarowicz
K, Krupka-Olek M, Bożek A, Kawczyk-Krupka A,
Bartusik-Aebisher D.
Current
Photodynamic Therapy for Glioma Treatment: An
Update.
Biomedicines.
2024 Feb 6;12(2):375. doi:
10.3390/biomedicines12020375. PMID:
38397977. Review. ˍ
Collado J, Boland L, Ahrendsen JT, Miska J, Lee-Chang
C.
Understanding the glioblastoma tumor
microenvironment: leveraging the extracellular matrix to increase
immunotherapy efficacy.
Front
Immunol. 2024 Feb 6;15:1336476. doi:
10.3389/fimmu.2024.1336476. PMID:
38380331. Review. ˍ
Cooper
BT, Mayo CS, Milano MT, Olch AJ, Oh C, Keating GF, Hallstrom A,
Constine LS, Laack NN.
Predictive
Factors Associated With Radiation Myelopathy in Pediatric Patients
With Cancer: A PENTEC Comprehensive Review.
Int
J Radiat Oncol Biol Phys.
2024 Feb 6:S0360-3016(23)08256-1. doi:
10.1016/j.ijrobp.2023.12.020. PMID:
38323945. Review˰ ˍ
Dai J, Jiang Y, Hu H, Zhang S, Chen Y.
Extracellular
vesicles as modulators of glioblastoma progression and tumor
microenvironment.
Pathol
Oncol Res. 2024 Feb 6;30:1611549. doi:
10.3389/pore.2024.1611549. PMID:
38379858. Review. ˍ
Hashemi M, Mousavian Roshanzamir S, Orouei S, Daneii P, Raesi R,
Zokaee H, Bikarannejad P, Salmani K, Khorrami R, Deldar Abad
Paskeh M, Salimimoghadam S, Rashidi M, Hushmandi K, Taheriazam A,
Entezari M.
Shedding light on function
of long non-coding RNAs (lncRNAs) in glioblastoma.
Noncoding
RNA Res. 2024 Feb 6;9(2):508-522. doi:
10.1016/j.ncrna.2024.02.002. PMID:
38511060. Review. ˍ
*Kiel K, Król SK, Bronisz A, Godlewski J.
MiR-128-3p
- a gray eminence of the human central nervous system.
Mol
Ther Nucleic Acids. 2024 Feb 6;35(1):102141. doi:
10.1016/j.omtn.2024.102141. PMID:
38419943. Review. ˍ
Wamelink
IJHG, Azizova A, Booth TC, Mutsaerts HJMM, Ogunleye A, Mankad K,
Petr
J, Barkhof F, Keil VC.
Brain
Tumor Imaging without Gadolinium-based
Contrast
Agents: Feasible or Fantasy?
Radiology.
2024 Feb 6;310(2):e230793.
doi:
10.1148/radiol.230793.
PMID:
38319162. Review˰
ˍ
Xu
F, Yang YH, Yang H, Li W, Hao Y, Zhang S, Zhang YZ, Cao WX, Li XX,
Du GH, Ji
TF, Wang JH.
Progress
of studies on natural products for glioblastoma
therapy.
J
Asian Nat Prod Res.
2024 Feb 6:1-23. doi:
10.1080/10286020.2023.2300367.
PMID:
38321773. Review˰
ˍ
Ageenko A, Vasileva N, Richter V, Kuligina E.
Combination
of Oncolytic Virotherapy with Different Antitumor Approaches
against Glioblastoma.
Int
J Mol Sci. 2024 Feb 7;25(4):2042. doi:
10.3390/ijms25042042. PMID:
38396720. Review. ˍ
Bali
B, Sellers A, Chinea A, Jallo GI, Shimony N.
Intramedullary
spinal cord tumors in pediatric patients presenting later with
brain lesions: case series and systematic review of the
literature.
Childs
Nerv Syst.
2024 Feb 7. doi:
10.1007/s00381-024-06311-0. PMID:
38321255. Case report, Review˰ ˍ
Koosha F, Ahmadikamalabadi M, Mohammadi M.
Review
of Recent Improvements in Carbon Ion Radiation Therapy in the
Treatment of Glioblastoma.
Adv
Radiat Oncol. 2024 Feb 8;9(5):101465. doi:
10.1016/j.adro.2024.101465. PMID:
38770179. Review. ˍ
Pizzimenti C, Fiorentino V, Germanò A, Martini M, Ieni A,
Tuccari G.
Pilocytic astrocytoma: The
paradigmatic entity in low-grade gliomas (Review).
Oncol
Lett. 2024 Feb 8;27(4):146. doi:
10.3892/ol.2024.14279. PMID:
38385109. Review. ˍ
Virtanen PS, Ortiz KJ, Patel A, Blocher WA 3rd, Richardson
AM.
Blood-Brain Barrier Disruption for
the Treatment of Primary Brain Tumors: Advances in the Past
Half-Decade.
Curr
Oncol Rep. 2024 Feb 8. doi:
10.1007/s11912-024-01497-7. PMID:
38329660. Review˰
ˍ
Cohen
KJ,
et al, PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma Treatment (PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ.
2024
Feb
9.
NCBI
Bookshelf ID:
NBK65935.
PMID:
26389373.
Review.
ˍ
Moreira DC, Bouffet E, Qaddoumi I.
The
greatest challenge for pediatric low-grade glioma.
Neuro
Oncol. 2024 Feb 10:noae004. doi:
10.1093/neuonc/noae004. PMID:
38339843. Letter. ˍ
Related
article:
Fangusaro
J, Jones DT, Packer RJ, Gutmann DH, Milde T, Witt O, Mueller S,
Fisher MJ, Hansford JR, Tabori U, Hargrave D, Bandopadhayay
P.
Pediatric
low-grade glioma: State-of-the-art and ongoing challenges.
Neuro
Oncol.
2023 Nov 7:noad195. doi:
10.1093/neuonc/noad195. PMID:
37944912. Review. ˍ
Virani QU, Javed Z, Shamim MS.
Evolution
of RANO in Assessing Brain Tumour Outcomes.
J
Pak Med Assoc. 2024 Feb 11;74(3):595-596. doi:
10.47391/JPMA.24-19. PMID:
38591309. Review. ˍ
Consales A, Skoch J, Tovar-Spinoza Z.
Editorial:
Magnetic resonance-guided laser interstitial thermal therapy
(MRg-LiTT) in the minimally invasive surgical treatment of
epilepsy and/or brain neoplasms.
Front
Neurol. 2024 Feb 12;15:1378585. doi:
10.3389/fneur.2024.1378585. PMID:
38410196. Editorial. ˍ
Habibi MA, Mirjani MS, Ahmadvand MH, Delbari P, Alasti O.
The
safety and efficacy of dabrafenib and trametinib in patients with
glioma: A systematic review and meta-analysis.
Eur
J Clin Pharmacol. 2024 Feb 12. doi:
10.1007/s00228-024-03635-3. PMID:
38345637. Review,
Meta-analysis˰ ˍ
Kudruk S, Forsyth CM, Dion MZ, Hedlund Orbeck JK, Luo J, Klein RS,
Kim AH, Heimberger AB, Mirkin CA, Stegh AH, Artzi N.
Multimodal
neuro-nanotechnology: Challenging the existing paradigm in
glioblastoma therapy.
Proc
Natl Acad Sci U S A. 2024 Feb 12;121(8):e2306973121.
doi:
10.1073/pnas.2306973121. PMID:
38346200. Perspective˰
ˍ
Regmi M, Wang Y, Liu W, Dai Y, Liu S, Ma K, Lin G, Yang J, Liu H,
Wu J, Yang C.
From glioma gloom to
immune bloom: unveiling novel immunotherapeutic paradigms-a
review.
J
Exp Clin Cancer Res. 2024 Feb 12;43(1):47. doi:
10.1186/s13046-024-02973-5. PMID:
38342925. Review.
ˍ
Watanabe G, Wong JM, Estes B, Khan MF, Ogasawara C, Umana GE,
Martin AR, Bloch O, Palmisciano P.
Diffuse
Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic
Review.
J
Neurooncol. 2024 Feb 12. doi:
10.1007/s11060-024-04584-8. PMID:
38342826. Review˰
ˍ
Bodensohn R, Haehl E, Belka C, Niyazi M.
Fractionated
radiotherapy for spinal tumors: A literature review regarding
spinal glioma, ependymoma, and meningioma.
Neurooncol
Adv. 2024 Feb 13;6(Suppl 3):iii101-iii109. doi:
10.1093/noajnl/vdad158. PMID:
39430392. Review. ˍ
Eugene T, Roy Sg J, S N, Rappai M.
Assessment
of the Efficacy of Circulating Tumor Cells by Liquid Biopsy in the
Diagnosis and Prediction of Tumor Behavior of Gliomas: A
Systematic Review.
Cureus.
2024 Feb 13;16(2):e54101. doi:
10.7759/cureus.54101. PMID:
38357405. Review. ˍ
Kresbach C, Hack K, Ricklefs F, Schüller U.
Specifics
of spinal neuropathology in the molecular age.
Neurooncol
Adv. 2024 Feb 13;6(Suppl 3):iii3-iii12. doi:
10.1093/noajnl/vdad127. PMID:
39430396. Review. ˍ
*Liguori GL.
Challenges and Promise for
Glioblastoma Treatment through Extracellular Vesicle
Inquiry.
Cells.
2024 Feb 13;13(4):336. doi:
10.3390/cells13040336. PMID:
38391949. Review. ˍ
Mirian C, Thastrup M, Mathiasen R, Schmiegelow K, Olsen JV,
Østergaard O.
Mass
spectrometry-based proteomics of cerebrospinal fluid in pediatric
central nervous system malignancies: a systematic review with
meta-analysis of individual patient data.
Fluids
Barriers CNS. 2024 Feb 13;21(1):14. doi:
10.1186/s12987-024-00515-x. PMID:
38350915. Review.
ˍ
Tonn JC, Teske N, Karschnia P.
Astrocytomas
of the spinal cord.
Neurooncol
Adv. 2024 Feb 13;6(Suppl 3):iii48-iii56. doi:
10.1093/noajnl/vdad166. PMID:
39430394. Review. ˍ
Wagner MW, Jabehdar Maralani P, Bennett J, Nobre L, Lim-Fat MJ,
Dirks P, Laughlin S, Tabori U, Ramaswamy V, Hawkins C, Ertl-Wagner
BB.
Brain Tumor Imaging in Adolescents
and Young Adults: 2021 WHO Updates for Molecular-based Tumor
Types.
Radiology.
2024 Feb 13;310(2):e230777. doi:
10.1148/radiol.230777. PMID:
38349246. Review.
ˍ
Xing Y, Yasinjan F, Cui J, Peng Y, He M, Liu W, Hong
X.
Advancements and current trends in
tumor treating fields: a scientometric analysis.
Int
J Surg. 2024 Feb 13. doi:
10.1097/JS9.0000000000001151. PMID:
38349201. Bibliographic analysis. ˍ
Furnari FB, Anastasaki C, Bian S, Fine HA, Koga T, Le LQ,
Rodriguez FJ, Gutmann DH.
Stem cell
modeling of nervous system tumors.
Dis
Model Mech. 2024 Feb 14;17(2):dmm050533. doi:
10.1242/dmm.050533. PMID:
38353122. Review.
ˍ
Garaba A, Aslam N, Ponzio F, Panciani PP, Brinjikji W, Fontanella
M, De Maria L.
Radiomics for
differentiation of gliomas from primary central nervous system
lymphomas: a systematic review and meta-analysis.
Front
Oncol. 2024 Feb 14;14:1291861. doi:
10.3389/fonc.2024.1291861. PMID:
38420015. Review;
Meta-analysis. ˍ
Newton HB, Wojkowski J.
Antiepileptic
Strategies for Patients with Primary and Metastatic Brain
Tumors.
Curr
Treat Options Oncol. 2024 Feb 14. doi:
10.1007/s11864-024-01182-8. PMID:
38353859. Review.
ˍ
Sheng H, Li H, Zeng H, Zhang B, Lu Y, Liu X, Xu Z, Zhang J, Zhang
L.
Heterogeneity and tumoral origin of
medulloblastoma in the single-cell era.
Oncogene.
2024 Feb 14. doi:
10.1038/s41388-024-02967-9. PMID:
38355808. Review. ˍ
Ezzati S, Salib S, Balasubramaniam M, Aboud O.
Epidermal
Growth Factor Receptor Inhibitors in Glioblastoma: Current Status
and Future Possibilities.
Int
J Mol Sci. 2024 Feb 15;25(4):2316. doi:
10.3390/ijms25042316. PMID:
38396993. Review. ˍ
Fangusaro J, Avery RA, Fisher MJ, Packer RJ, Walsh KS,
Schouten-van Meeteren A, Karres D, Bradford D, Bhatnagar V, Singh
H, Kluetz PG, Donoghue M, Duke ES.
Considering
Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade
Glioma Clinical Trials: An FDA Educational Symposium.
Clin
Cancer Res. 2024 Feb 15. doi:
10.1158/1078-0432.CCR-23-3386. PMID:
38358393. Meeting report˰
ˍ